Tirzepatide for Treatment of CCCA

NCT07734870 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Central Centrifugal Cicatricial Alopecia (CCCA)

Interventions

DRUG: Tirzepatide

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]